08/29/2024 | Press release | Distributed by Public on 08/29/2024 14:07
As filed with the Securities and Exchange Commission on August 29, 2024
Registration No. 333-
|
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
|
|
FORM S-8
REGISTRATION STATEMENT
Under the
Securities Act of 1933
|
|
MERIT MEDICAL SYSTEMS, INC.
(Exact name of registrant as specified in its charter)
Utah (State or other jurisdiction of incorporation or organization) |
87-0447695 (I.R.S. Employer Identification No.) |
|
|
1600 West Merit Parkway
South Jordan, Utah 84095
Telephone: (801) 253-1600
(Address of Principal Executive Offices,
including Zip Code)
Merit Medical Systems, Inc.
2018 Long-Term Incentive Plan
(Full title of the plan)
and Corporate Secretary |
|
Brian G. Lloyd Chief Legal Officer and Corporate Secretary Merit Medical Systems, Inc. 1600 West Merit Parkway South Jordan, Utah 84095 (801) 253-1600 (Name, address and telephone number, including area code, of agent for service) |
Copy to: Dane Johansen Parr Brown Gee & Loveless 101 South 200 East, Suite 700 Salt Lake City, Utah 84111 (801) 532-7840 |
|
|
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer", "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer þ |
Accelerated filer ◻ |
Non-accelerated filer ◻ (Do not check if a smaller reporting company) |
Smaller reporting company ◻ |
|
Emerging growth company ◻ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ◻
|
|
EXPLANATORY NOTE
This Registration Statement on Form S-8 is filed pursuant to General Instruction E to Form S-8 for the purpose of registering an additional 3,000,000 shares of the common stock, no par value, (the "Common Stock"), of Merit Medical Systems, Inc. (the "Registrant") issuable under the Merit Medical Systems, Inc. 2018 Long-Term Incentive Plan, as amended (the "Incentive Plan"). The Registrant's shareholders approved the addition of these shares to the Incentive Plan at the Registrant's Annual Meeting of Shareholders held on May 15, 2024.
Pursuant to General Instruction E to Form S-8, this Registration Statement incorporates by reference the contents of the Registrant's previously filed Registration Statement on Form S-8, File No. 333-225426, filed with the Securities and Exchange Commission (the "Commission") on June 4, 2018relating to the Incentive Plan, to the extent not otherwise amended or superseded by the contents hereof. In accordance with the instructional note to Part I of Form S-8 as promulgated by the Commission, the information specified by Part I of Form S-8 has been omitted from this Registration Statement.
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 3.Incorporation of Documents by Reference.
The following documents filed by the Registrant with the Commission are hereby incorporated herein by reference:
(1) | The Registrant's Annual Report on Form 10-K for the year ended December 31, 2023 filed with the Commission on February 28, 2024 (our "2023 Annual Report"); |
(2) | The Registrant's Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2024, filed with the Commission on April 30, 2024; |
(3) | The Registrant's Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2024, filed with the Commission on August 1, 2024; |
(4) | The Registrant's Current Reports on Form 8-K, other than with respect to Items 2.02 or 7.01, filed with the Commission on January 8, 2024, February 28, 2024, April 30, 2024, May 16, 2024, May 21, 2024, July 1, 2024 and August 1, 2024; |
(5) | The Registrant's Definitive Proxy Statement on Schedule 14A for the annual meeting of shareholders held on May 15, 2024, filed with the Commission on April 2, 2024; and |
(6) | The description of the Common Stock contained in the Registrant's Registration Statement on Form 8-A filed with the Commission on May 11, 1990, including any amendment or report filed for the purpose of updating such description. |
In addition, all documents subsequently filed by the Registrant pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), other than documents or information deemed to have been furnished and not filed in accordance with SEC rules, prior to the filing of a post-effective amendment that indicates that all securities offered have been sold or that deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference in this Registration Statement and to be a part hereof from the date of filing of such documents. Any statement contained in a document incorporated by reference herein shall be deemed to be modified or superseded for purposes hereof to the extent that a statement contained herein (or in any other subsequently filed document which is also incorporated by reference herein) modifies or supersedes such statement. Any statement so modified or superseded shall not be deemed to constitute a part hereof except as so modified or superseded.
Under no circumstances will any information furnished under Items 2.02 or 7.01 of Form 8-K be deemed incorporated herein by reference unless such Form 8-K expressly provides to the contrary.
Item 8. Exhibits.
|
|
|
|
Exhibit |
Description |
Filing Status |
|
5.1 |
|
Opinion of Parr Brown Gee & Loveless PC |
Filed herewith |
104.1 |
|
Merit Medical Systems, Inc., 2018 Long-Term Incentive Plan (included as Exhibit 4.2 to the Registrant's registration statement on Form S-8 filed with the Commission on June 4, 2018) |
Form S-8, filed June 4, 2018 (Exhibit No. 4.2) |
104.2 |
|
Schedule 14A, filed April 2, 2024 (Appendix B) |
|
23.1 |
|
Consent of Deloitte & Touche LLP |
Filed herewith |
23.2 |
|
Consent of Parr Brown Gee & Loveless |
Included in Exhibit 5.1, which is filed herewith |
24.1 |
|
Power of Attorney |
Included in signature pages hereto |
107 |
|
Calculation of filing fee tables |
Filed herewith |
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in South Jordan, State of Utah, on August 29, 2024.
|
|
|
MERIT MEDICAL SYSTEMS, INC. |
|
|
|
/s/ FRED P. LAMPROPOULOS Fred P. Lampropoulos Chairman of the Board and Chief Executive Officer |
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature to this registration statement appears below hereby constitutes and appoints Fred P. Lampropoulos (Chief Executive Officer), Raul Parra (Chief Financial Officer and Treasurer) and Brian G. Lloyd (Chief Legal Officer and Corporate Secretary), and each of them acting individually, as his or her true and lawful attorney-in-fact and agent, with full power of substitution, to sign on his or her behalf individually and in the capacity stated below and to perform any acts necessary to be done in order to file all amendments (including any post-effective amendments) to this registration statement, and any and all instruments or documents filed as part of or in connection with this registration statement or the amendments thereto, and to file the same with the Securities and Exchange Commission, granting unto say attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in or about the premises, as fully to all intents and purposes as he or she might or could do in person, and each of the undersigned does hereby ratify and confirm all that such attorneys-in-fact and agents, or any of them or their respective substitutes, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities indicated on August 29, 2024.
|
|
|
Signature |
|
Capacity in Which Signed |
|
|
|
/s/ FRED P. LAMPROPOULOS |
|
Chief Executive Officer and Director |
Fred P. Lampropoulos |
|
(Principal executive officer) |
|
|
|
/s/ RAUL PARRA |
|
Chief Financial Officer and Treasurer |
Raul Parra |
|
(Principal financial and accounting officer) |
|
|
|
/s/ LONNY J. CARPENTER |
|
Director |
Lonny J. Carpenter |
|
|
|
|
|
/s/ STEPHEN C. EVANS |
|
Director |
Stephen C. Evans |
|
|
|
|
|
/s/ DAVID K. FLOYD |
|
Director |
David K. Floyd |
|
|
|
|
|
/s/ THOMAS J. GUNDERSON |
|
Director |
Thomas J. Gunderson |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Signature |
|
Capacity in Which Signed |
|
|
|
/s/ LAURA S. KAISER |
|
Director |
Laura S. Kaiser |
|
|
|
|
|
/s/ MICHAEL R. MCDONNELL |
|
Director |
Michael R. McDonnell |
|
|
|
|
|
/s/ F. ANN MILLNER |
|
Director |
F. Ann Millner |
|
|
|
|
|
/s/ SILVIA M. PEREZ |
|
Director |
Silvia M. Perez |
|
|
|
|
|
/s/ LYNNE N. WARD |
|
Director |
Lynne N. Ward |
|
|